Missouri Compounder Warned for Insanitary Conditions, CGMP Violations

Drug Industry Daily
A A
Adulterated products and contamination risks landed Columbia, Missouri compounder Apollo Care a warning letter from the FDA, in a follow up to a Form 483 report the agency issued after a March 2018 inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily